ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0135

Understanding the Rheumatologist-Patient Relationship in Treating Rheumatoid Arthritis

Beth Schneider1 and Eric Peacock1, 1MyHealthTeams, San Francisco, CA

Meeting: ACR Convergence 2020

Keywords: Patient reported outcomes, quality of care, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Friday, November 6, 2020

Title: Patient Outcomes, Preferences, & Attitudes Poster I: RA, Spondyloarthritis, & OA

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Understanding patient satisfaction with their rheumatologist and the drivers of satisfaction is crucial to improving doctor-patient interactions, helping patients get on the right treatment path to help slow progression and improving health outcomes overall.

Methods: In January 2020 an email invitation to an online survey was sent to US members of myRAteam, a social network of over 122,000 members. In total, 374 US members completed the 21-question survey regarding the HCP-patient experience.

Results: Over half of RA patients surveyed are satisfied with their HCP (57%) and 78% feel they are able to have meaningful conversations. The majority feel they’re HCP is doing a good job of recommending regular checks-ups (77%) and medications (66%) based on the patient’s unique needs. Slightly less than two-thirds feel they’re doctor listens to them and truly understands what they are going through (61%) or spends enough time with them (58%). While biggest obstacles to managing RA are pain (80%), relentless fatigue (72%) and depression/anxiety (51%), only 51% of patients feel their HCP addresses these symptoms. Further, only 37% are satisfied with their current treatment and only 49% feel their HCP is adequately discussing potential side effects and 47% treatment efficacy. And only 35% feel their HCP has developed a long-term plan for treating this progressive disease. There is a significant delta in experiences among those who are satisfied versus dissatisfied with their HCP. 61% of satisfied patients feel their treatment is working versus only 7% who are dissatisfied with their HCP. 87% of satisfied patient feel their HCP listens to and understands them versus 24% of dissatisfied patients. Likewise, 81% of satisfied patients feel their HCP spends enough time with them versus 26% among dissatisfied patients. 74% of satisfied patients feel their doctor addresses symptoms like pain and depression versus 20% of dissatisfied patients. 

Conclusion: Understanding the needs of RA patients provides significant opportunities for rheumatologists to better support and educate their patients. This includes offering a stronger recommendation on treatment path based on the patient’s specific needs and goals, and specific information on diet/exercise approaches. It also means listening to patient concerns and addressing the mental health aspects of RA including pain, depression and fatigue, and not just disease progression.

Experiences with HCPs

Satisfaction with HCP


Disclosure: B. Schneider, None; E. Peacock, None.

To cite this abstract in AMA style:

Schneider B, Peacock E. Understanding the Rheumatologist-Patient Relationship in Treating Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/understanding-the-rheumatologist-patient-relationship-in-treating-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/understanding-the-rheumatologist-patient-relationship-in-treating-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology